This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Antipsychotics and breastfeeding

Authoring team

A review notes (1):

  • haloperidol is the preferred choice first-generation antipsychotic during breastfeeding, due to its favourable side effect profile
  • quetiapine is the preferred choice second-generation antipsychotic due to its low excretion into milk and favourable pharmacokinetics
    • olanzapine also has favourable pharmacokinetics in this clinical scenario
  • is no need to change an antipsychotic used successfully during pregnancy to a preferred choice in breastfeeding if the infant is full term and healthy

Risk of SIDS whilst using antipsychotics

  • sudden infant death syndrome (SIDS) is very rare, and breastfeeding reduces the risk
    • however it is more likely to happen in certain circumstances, including when parents have taken sedating medicines such as antipsychotics.
      • NICE therefore advises avoiding sharing a bed with the infant when sedating medicines are used

Neonatal withdrawal syndrome and use of antipsychotics during breastfeeding

  • withdrawal symptoms and poor neonatal adaptation syndrome have been reported in infants exposed to antipsychotic medicines in pregnancy
    • is more likely to occur for exposure near delivery or when more than one centrally acting medicine is used
    • continuing breastfeeding may theoretically help relieve withdrawal effects but does not reduce the risk completely

General side effects with respect to use of antispychotics during breastfeeding

  • use of antipsychotics may lead to more difficulties with breastfeeding, particularly establishing breastfeeding
    • underlying disease state might contribute and additional breastfeeding support may be required
  • antipsychotics may increase prolactin levels which can cause milk secretion in non-breastfeeding patients
    • clinical significance of this in those breastfeeding is unknown
  • aripiprazole can both increase and decrease prolactin levels
    • have been multiple reports of reduced milk supply or an inability to breastfeed in patients taking aripiprazole.
    • where breastfeeding is established, this is less likely to have an effect

Infant side effects and development

  • antipsychotics have long half-lives, which increases the risk of accumulation in breastfed infants, and the risk of side-effects
  • are limited data on the neurodevelopmental effects of long-term exposure of infants to antipsychotics during breastfeeding.
    • most studies do not report any effects
      • note though that there are reports of developmental delays, mainly when antipsychotics have been used with other psychotropic medicines
        • the data have limitations and the implications of these findings are unclear

Specific information with respect to haloperidol

  • use with caution
    • oral haloperidol can be used with caution during breastfeeding, but infant monitoring is required
  • infant monitoring
    • monitor the infant for potential side-effects including drowsiness, irritability, restlessness, gastro-intestinal disturbances, urinary retention (producing fewer wet nappies), rash, extrapyramidal symptoms, not feeding as normal or gaining weight as expected, and attainment of developmental milestones
  • further information
    • limited evidence indicates that oral doses of up to 10mg daily result in variable, yet small to moderate amounts in milk (0.3 to 12% of the weight-adjusted maternal dose)
    • haloperidol has been detected in breastfed infant serum, at levels which could be significant, and in urine
      • most studies have not reported side-effects in breastfed infants.
    • one infant developed hypersomnia, poor feeding and slowing in motor movements when exposed to haloperidol and risperidone via milk
    • in three infants exposed to chlorpromazine and haloperidol, a decline in developmental scores was reported at 12 to 18 months of age
      • other studies have found no developmental problems at 18 months and, in one case 8 years

Specific information with respect to quetiapine

  • use with caution
    • oral quetiapine can be used with caution during breastfeeding, but infant monitoring is required.
  • infant monitoring
    • monitor the infant for potential side-effects including drowsiness, irritability, restlessness, gastro-intestinal disturbances, fever, extrapyramidal symptoms, not feeding as normal or gaining weight as expected, and attainment of developmental milestones
  • further information
    • moderate evidence shows that oral doses up to 400mg daily result in negligible amounts in milk (0.4% of the weight-adjusted maternal dose)
    • infant serum levels of quetiapine are low ranging from 0.6 to 7.3% of the maternal serum level
      • most studies have not reported short or long term side-effects in breastfed infants
        two infants showed mild developmental delays however, infant quetiapine levels were undetectable and an antidepressant was also taken whilst breastfeeding; causality to the medicines in milk was unlikely

For full details see https://www.sps.nhs.uk/articles/using-antipsychotics-during-breastfeeding/

Reference:

  1. NHS Speciality Pharmacy Service (July 14th 2025). Using antipsychotics during breastfeeding

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.